Visualizando por Autor LIN, XUN
Mostrando reg. 1 a 6 de 6
Fecha de Publicación | Título | Autor(s) |
2016 | Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy | TEMPLETON, ARNOUD J.; KNOX, JENNIFER J.; LIN, XUN, etc. |
2018 | Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database | André Poisl Fay; MCKAY, RANA R.; LIN, XUN, etc. |
2018 | Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database | André Poisl Fay; MCKAY, RANA R.; LIN, XUN, etc. |
2022 | Plain language summary of the design of the TALAPRO-2 study comparing talazoparib and enzalutamide versus enzalutamide and placebo in men with metastatic castration-resistant prostate cancer | AGARWAL, NEERAJ; AZAD, ARUN; SHORE, NEAL D, etc. |
2016 | Statins and survival outcomes in patients with metastatic renal cell carcinoma | MCKAY, RANA R.; LIN, XUN; ALBIGES, LAURENCE, etc. |
2022 | Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 phase III study design | AGARWAL, NEERAJ; AZAD, ARUN; SHORE, NEAL D, etc. |